论文部分内容阅读
为评价急性心肌梗塞溶栓疗法的长期疗效和存活率,多个医学中心进行了4年的临床观察。533例患者在症状发生后4小时内收入冠心病监护病房,随机分别给予冠状动脉内链激酶注射组或传统疗法而且不作血管造影组。在最后一年行血管造影前,静脉注射链激酶500,000单位,溶栓后残余的
To evaluate the long-term efficacy and survival of thrombolytic therapy in acute myocardial infarction, a number of medical centers conducted a 4-year clinical observation. 533 patients were admitted to the coronary care unit within 4 hours of symptom onset and were randomized to receive intracoronary streptokinase or conventional therapy without angiography. Prior to angiography in the final year, 500,000 units of streptokinase were intravenously injected and remained after thrombolysis